Archives

It has been a terrible summer for stock market investors. Literally, the markets did not go anywhere. Take the CAC 40 index – the leading French stock market index. After trading close to 7,600 points in May, it began a long consolidation that still stretches. News has not been particularly bullish on both sides of […] The post CAC 40 forecast: bullish flag pattern points to more upside appeared first on Invezz.

• September 27, 2023 01:00 AM PDT
• Invezz

American stocks have come under intense pressure in the past few weeks as the fear and greed index is nearing the extreme fear zone of 25. The Dow Jones has dropped by more than 5.5% from its highest point this year. Similarly, the Nasdaq 100 and S&P 500 indices have slipped by over 8.8% and […]

• September 26, 2023 11:22 PM PDT
• Invezz

Nio (NYSE: NIO) stock price will be in the spotlight in the next few days as the company unveils its smartphone. The shares plunged to a low of $8 on Tuesday, the lowest level since June 23rd. They have retreated by more than 48% from the highest level in August. Nio Inc. is facing major […] The post Nio stock price forecast: smartphone is a drag, not a catalyst appeared first on Invezz.

• September 26, 2023 09:30 PM PDT
• Invezz

Roivant Sciences (NASDAQ: ROIV) stock price surged on Tuesday as investors cheered the latest developments with Immunovant (NASDAQ: IMVT). The shares jumped by more than 20% and retested the year-to-date high of $12.90. They have soared by more than 390% from the lowest point in 2022. Encouraging Immunovant data Roivant Sciences is a biotech company, […] The post Roivant stock price outlook: strong pipeline is a catalyst appeared first on Invezz.

• September 26, 2023 07:12 PM PDT
• Invezz

Femasys (NASDAQ: FEMY) stock price has made a strong comeback in the past few days as investors cheer the company’s FDA news. The shares surged to a high of $1.71, the highest level since October last year. They have soared by more than 320% from the lowest point this year. Femasys FDA approval Femasys is […] The post FEMY stock price has surged: Is Femaysis still a good buy? appeared first on Invezz.

• September 26, 2023 05:05 PM PDT
• Invezz

Costco Wholesale Corporation (NASDAQ: COST) is trading down in extended hours even though it reported market-beating results for its fiscal fourth quarter. Jefferies analyst shares his view on Costco Even though the membership warehouse retailer came in ahead of Street estimates – pockets of weakness in the United States were evident in its earnings release. […] The post Costco Q4 earnings: ‘you need to be a bit hesitant’ appeared first on Invezz.

• September 26, 2023 02:03 PM PDT
• Invezz

New York, United States, September 26th, 2023, Chainwire Decrypt Media Inc. has officially announced 1000x, the first loyalty program for degens. The announcement comes on the heels of the launch of Degen Alley, an expansion of the site’s editorial coverage into new and barely explored corners of the crypto space. Degen Alley embraces the “degenerate” […] The post Decrypt Introduces the 1000x Loyalty Program and Destination for Financial Entertainment appeared first on Invezz.

• September 26, 2023 01:15 PM PDT
• Invezz

Rivian Automotive Inc (NASDAQ: RIVN) is currently down 20% versus its year-to-date high but a Baird analyst is convinced that a full recovery is coming soon. Rivian to report quarterly deliveries next week Ben Kallo expects the electric vehicles company to come in ahead of Street estimates as it reports its quarterly deliveries next week. […] The post Rivian stock price forecast: Baird analyst sees a 35% upside appeared first on Invezz.

• September 26, 2023 12:16 PM PDT
• Invezz

T2 Biosystems (NASDAQ: TTOO) stock price sell-off continued as the company continued facing numerous headwinds. The shares dropped to a low of $0.1884 on Tuesday, the lowest level since August 2nd. It has dropped by more than 70% from its highest point in August and by almost 100% from its all-time high. T2 Biosystems is […] The post TTOO stock price outlook as big shareholder dumps shares appeared first on Invezz.

• September 26, 2023 10:12 AM PDT
• Invezz

W.P Carey (NYSE: WPC) stock price has been in a strong freefall in the past few months. This sell-off gained steam this month when the company made huge changes to its business and effectively slashed their dividend. The stock plunged to a low of $53.98 on Tuesday, the lowest level since November 2022.  Avoids being […]

• September 26, 2023 09:31 AM PDT
• Invezz